global market

discovery
technologies
services
applications
disease
indications
omics
technology
imaging
technology
bioinformatics
sample
preparation
assay
development
biomarker
validation
testing
drug discovery and
formulation
development of
molecular diagnostics
personalized medicine
oncology
cardiology
neurology
other diseases
(HIV, renal disorders,
diabetes,
arthritis, and tuberculosis)
advancements in discovery technologies,
high demand from the indications of
various diseases, increasing partnerships and
collaborations to boost biomarker
research activities, increase in government
and private sector investments and funds
for biomarker discovery, FDA support for
biomarker development, and increasing
utility of biomarkers in patient stratification
and drug development process are the
major drivers slated to propel the growth of
this market.
However, a few pivotal
factors such as the high capital
investment and low benefit-cost
ratio, cumbersome
biomarker validation procedure,
and difficulty in sample collection
and its storage are
expected to hamper the growth of
this market.